These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20155608)

  • 21. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
    Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
    Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
    Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
    J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reported hepatitis C virus antibody status and risk behavior in young injectors.
    Hagan H; Campbell J; Thiede H; Strathdee S; Ouellet L; Kapadia F; Hudson S; Garfein RS
    Public Health Rep; 2006; 121(6):710-9. PubMed ID: 17278406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
    Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India.
    Solomon SS; Celentano DD; Srikrishnan AK; Vasudevan CK; Murugavel KG; Iqbal SH; Anand S; Kumar MS; Latkin C; Solomon S; Mehta SH
    Am J Epidemiol; 2010 Dec; 172(11):1259-67. PubMed ID: 20935070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.
    Garten RJ; Lai S; Zhang J; Liu W; Chen J; Vlahov D; Yu XF
    Int J Epidemiol; 2004 Feb; 33(1):182-8. PubMed ID: 15075167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.
    Villano SA; Vlahov D; Nelson KE; Lyles CM; Cohn S; Thomas DL
    J Clin Microbiol; 1997 Dec; 35(12):3274-7. PubMed ID: 9399533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
    Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
    Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.
    Garfein RS; Doherty MC; Monterroso ER; Thomas DL; Nelson KE; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S11-9. PubMed ID: 9663618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth.
    Hadland SE; DeBeck K; Kerr T; Feng C; Montaner JS; Wood E
    BMJ Open; 2014 Jul; 4(7):e005419. PubMed ID: 25052173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection among noninjecting drug users in New York City.
    Koblin BA; Factor SH; Wu Y; Vlahov D
    J Med Virol; 2003 Jul; 70(3):387-90. PubMed ID: 12767001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can intranasal drug use reduce HCV infection among injecting drug users?
    Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Semaan S; Perlman DC
    Drug Alcohol Depend; 2011 Dec; 119(3):201-6. PubMed ID: 21794991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High hepatitis C incidence in new injecting drug users: a policy failure?
    Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
    Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.